Randomized clinical trials and placebo
Subtitle: can you trust the drugs are working and safe?
By: editors, Søren Ventegodt, Joav Merrick
Series: Pharmacology-research, safety testing, and regulation series; Public health in the 21st century series; Pharmacology-research, safety testing, and regulation series; Public health in the 21st century series
Publisher: Nova Science Publisher's, Inc.
Published: 2011
Place of publication: Hauppauge, N.Y
Language: eng
ISBN-13: 9781614700678
Subjects: Clinical trials; Placebos (Medicine); Drugs; Placebos; Drug Toxicity; Toxicology; Treatment Outcome; Randomized Controlled Trials as Topic
Notes: Includes bibliographical references and index.
Table of contents: title: The errors and deficiencies of the randomised, clinical trial (RCT); title: Problems with the premises of the RCT: the placebo pill has no placebo effect at all so the drugs win the race; title: Passive or active placebo; title: Measuring the effect of drugs in RTC. Shall documentation be based on disease markers, local symptoms, or global dimensions of self-rated health, quality of life, and ability?; title: The observation time of the randomised clinical trial (RCT); title: Efficacy of biomedicine in general practice: why only one patient in a hundred gets help; title: The cost of a patient cured with biomedicine compared to the original, Hippocratic, holistic medicine; title: The chemical medicine's efficacy in the serious diseases. Somatic medicine: cancer and coronary heart disease. Psychiatry: depression and schizophrenia; title: The marketing strategy, the values, and the people of big pharma; title: Biomedicine and holistic medicine in conflict; title: How do we develop medicine from being poisonous drugs into being an efficient and safe medicine?; title: Conclusion: the pharmaceutical industry sells poisons as medicine and knows that the documentation should be better; title: Scientific résumé.